Episode 67
Biotech Hangout
00:00
The Pros and Cons of Tl1 A
Tl1a is a pretty interesting target. It was actually originally identified by geneticists. When you down regulate tl1 a You get activity on a whole bunch of different proinflammatory cytokines at once. So far these drugs have been developed principally in inflammatory bowel disease and ulcerative clays and crones. We've got data from other programs like from jng ran the study called vago where they combined a tnf with nile 23 That shows that there's a compounding maybe even kind of better than some of the parts effective combining multiple axis of anti-inflammation.
Transcript
Play full episode
